RICHARD ORNBERG: Open Payments
NPI 1255922936 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,841 in 106 payments from 13 companies in 2025. Trend: 2023 $741 · 2024 $2,030 · 2025 $2,841
Food & beverage: $2,841
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 40 | $1,363 |
| Gilead Sciences, Inc. | 21 | $591 |
| Merck Sharp & Dohme LLC | 10 | $236 |
| Novo Nordisk Inc | 12 | $179 |
| Theratechnologies Inc. | 5 | $126 |
| Lilly USA, LLC | 7 | $123 |
| PFIZER INC. | 3 | $61 |
| Lundbeck LLC | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| EMD Serono, Inc. | 1 | $26 |
Products named: DOVATO, APRETUDE, PIFELTRO, CABENUVA, Wegovy, EGRIFTA, MOUNJARO, Biktarvy.
Industry payments across TX — which companies pay providers there.
